NCT00384202View on ClinicalTrials.gov

A Conversion Study to Assess Safety and Efficacy of a MR4 Based Immunosuppressive Regimen in Stable Liver Recipients

PHASE3CompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
Transplantation
Interventions
DRUG

Tacrolimus

Immunosuppression

Trial Locations (13)

13353

Berlin

15706

Santiago de Compostela

20251

Hamburg

41013

Seville

46009

Valencia

48903

Barakaldo

67098

Strasbourg

69437

Lyon

94801

Villejuif

Dublin 4

Dublin

02-005

Warsaw

08035

Barcelona

B15 2TH

Birmingham

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY